Inventor
HENDERSON DANIEL R
US33 patents
⚠️ This page may combine multiple inventors who share the name “HENDERSON DANIEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL GENESYS INC
17 patentsUS6692736B2Feb 17, 2004
Cell-specific adenovirus vectors comprising an internal ribosome entry site
CELL GENESYS INC129 citations97
US6676935B2Jan 13, 2004
Tissue specific adenoviral vectors
CELL GENESYS INC102 citations97
US6436394B1Aug 20, 2002
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CELL GENESYS INC90 citations97
US6432700B1Aug 13, 2002
Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
CELL GENESYS INC65 citations96
US6991935B2Jan 31, 2006
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
CELL GENESYS INC16 citations92
US6916918B2Jul 12, 2005
Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
CELL GENESYS INC32 citations92
US6911200B2Jun 28, 2005
Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
CELL GENESYS INC30 citations92
US6900049B2May 31, 2005
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
CELL GENESYS INC26 citations92
US6852528B2Feb 8, 2005
Human and mouse uroplakin II gene transcriptional regulatory elements
CELL GENESYS INC26 citations92
US6585968B2Jul 1, 2003
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
CELL GENESYS INC36 citations91
US7575919B2Aug 18, 2009
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
CELL GENESYS INC11 citations84
US7319033B2Jan 15, 2008
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CELL GENESYS INC9 citations84
US7001764B2Feb 21, 2006
Compositions comprising tissue specific adenoviral vectors
CELL GENESYS INC14 citations82
US6406861B1Jun 18, 2002
Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration
CELL GENESYS INC12 citations74
US6673614B2Jan 6, 2004
Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody
CELL GENESYS INC7 citations73
US7276233B2Oct 2, 2007
Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
CELL GENESYS INC2 citations63
US7011976B1Mar 14, 2006
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
CELL GENESYS INC3 citations60
CALYDON INC
6 patentsUS6495130B1Dec 17, 2002
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
CALYDON INC54 citations96
US6197293B1Mar 6, 2001
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CALYDON INC54 citations95
US6254862B1Jul 3, 2001
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
CALYDON INC48 citations94
US6136792AOct 24, 2000
Prostate specific enhancer polynucleotides and methods of use thereof
CALYDON INC18 citations92
US6057299AMay 2, 2000
Tissue-specific enhancer active in prostate
CALYDON INC47 citations92
US6051417AApr 18, 2000
Prostate cancer drug screening using hKLK2 enhancer
CALYDON INC7 citations72
MICROGENICS CORP
3 patentsUS5604091AFeb 18, 1997
Methods for protein binding enzyme complementation
MICROGENICS CORP52 citations96
US4708929ANov 24, 1987
Methods for protein binding enzyme complementation assays
MICROGENICS CORP127 citations96
US5120653AJun 9, 1992
Vector comprising DNA sequence coding for enzyme-donor polypeptide
MICROGENICS CORP40 citations92